28 April 2022
Latham & Watkins Advises Zentalis Pharmaceuticals on US$25 Million Equity Investment from Pfizer
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | corporate | New York |
| Salvatore Vanchieri | Latham & Watkins LLP | Associate | corporate | New York |
| Matt DeSilva | Latham & Watkins LLP | Associate | corporate | New York |
| Darby Dietrich | Latham & Watkins LLP | Associate | corporate | New York |
| Darryl Steensma | Latham & Watkins LLP | Counsel | collaboration matters | San Diego |
| Pardis Zomorodi | Latham & Watkins LLP | Partner | tax matters | Los Angeles |
| Sam Weiner | Latham & Watkins LLP | Partner | tax matters | Century City |
| Ryan Brenner | Latham & Watkins LLP | Associate | tax matters | Century City |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy & security matters | Bay Area |
| Fiona Maclean | Latham & Watkins LLP | Partner | data privacy & security matters | London |
| Oliver Mobasser | Latham & Watkins LLP | Associate | data privacy & security matters | London |
| Lorenzo Meusburger | Latham & Watkins LLP | Associate | data privacy & security matters | London |
Stated terms
- Stated value
- USD 25m (US$25 million)
- What the figure measures
- Issue size
- Client
- Zentalis Pharmaceuticals, Inc.Issuer
- Counterparties
- Pfizer (Investor)